A Study of Eltrombopag and Recombinant Human Thrombopoietin In Primary Immune Thrombocytopenia

NCT04214951 · clinicaltrials.gov ↗

UNKNOWN

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Corticosteroid-resistant or Relapsed ITP

Interventions

DRUG: Eltrombopag
DRUG: Recombinant human thrombopoietin (rh-TPO)

Sponsor

Peking University People's Hospital